Astrocytes as a target for neuroprotection: Modulation by progesterone and dehydroepiandrosterone

Progress in Neurobiology

Volumn 144, Issue , 2016, Pages 27-47

  Arbo, Bruno Dutra ^a,b   Bennetti, Fernando ^a   Ribeiro, Maria Flavia ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b INSTITUTO CAJAL   (Spain)

Author keywords

Apoptosis; Brain injury; Neuroactive steroids; Neurodegeneration; Neurosteroids; Spinal cord injury

Indexed keywords

GLUTAMIC ACID; MEMBRANE RECEPTOR; NEUROPROTECTIVE AGENT; PRASTERONE; PROGESTERONE; PROGESTERONE MEMBRANE RECEPTOR; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ASTROCYTE; BRAIN INJURY; CELL FUNCTION; DRUG MECHANISM; EXCITOTOXICITY; EXPERIMENTAL STROKE; EXPERIMENTAL STUDY; HUMAN; MULTICENTER STUDY (TOPIC); NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURIES; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SPINAL CORD INJURIES;

ANIMALS; ASTROCYTES; BRAIN INJURIES; DEHYDROEPIANDROSTERONE; HUMANS; NEUROPROTECTION; PROGESTERONE; SPINAL CORD INJURIES;

EID: 84962747595     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2016.03.010     Document Type: Review

References (304)

1. Agís-Balboa, R.C., Pinna, G., Zhubi, A., Maloku, E., Veldic, M., Costa, E., Guidotti, A., Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 14602–14607.
2. Akwa, Y., Morfin, R.F., Robel, P., Baulieu, E.E., Neurosteroid metabolism. 7 alpha-hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes. Biochem. J. 288 (1992), 959–964.
3. Akwa, Y., Schumacher, M., Jung-Testas, I., Baulieu, E.E., Neurosteroids in rat sciatic nerves and Schwann cells. C. R. Acad. Sci. III 316 (1993), 410–414.
4. Alberdi, E., Sánchez-Gómez, M.V., Matute, C., Calcium and glial cell death. Cell Calcium 38 (2005), 417–425.
5. Alkayed, N.J., Murphy, S.J., Traystman, R.J., Hurn, P.D., Miller, V.M., Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 31 (2000), 161–168.
6. Anderson, C.M., Swanson, R.A., Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32 (2000), 1–14.
7. Andrade, S., Silveira, S.L., Arbo, B.D., Batista, B.A., Gomez, R., Barros, H.M., Ribeiro, M.F., Sex-dependent antidepressant effects of lower doses of progesterone in rats. Physiol. Behav. 99 (2010), 687–690.
8. Aragno, M., Parola, S., Brignardello, E., Mauro, A., Tamagno, E., Manti, R., Danni, O., Boccuzzi, G., Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 49 (2000), 1924–1931.
9. Arbo, B.D., Andrade, S., Osterkamp, G., Gomez, R., Ribeiro, M.F., Asymmetric effects of low doses of progesterone on GABA(A) receptor α4 subunit protein expression in the olfactory bulb of female rats. Can. J. Physiol. Pharmacol. 92 (2014), 1045–1049.
10. Arbo, B.D., Andrade, S., Osterkamp, G., Gomez, R., Ribeiro, M.F., Effect of low doses of progesterone in the expression of the GABA(A) receptor α4 subunit and procaspase-3 in the hypothalamus of female rats. Endocrine 46 (2014), 561–567.
11. Ardeshiri, A., Kelley, M.H., Korner, I.P., Hurn, P.D., Herson, P.S., Mechanism of progesterone neuroprotection of rat cerebellar Purkinje cells following oxygen-glucose deprivation. Eur. J. Neurosci. 24 (2006), 2567–2574.
12. Arevalo, M.A., Azcoitia, I., Garcia-Segura, L.M., The neuroprotective actions of oestradiol and oestrogen receptors. Nat. Rev. Neurosci. 16 (2015), 17–29.
13. Arvin, B., Neville, L.F., Barone, F.C., Feuerstein, G.Z., The role of inflammation and cytokines in brain injury. Neurosci. Biobehav. Rev. 20 (1996), 445–452.
14. Attella, M.J., Nattinville, A., Stein, D.G., Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav. Neural Biol. 48 (1987), 352–367.
15. Attwell, D., Buchan, A.M., Charpak, S., Lauritzen, M., Macvicar, B.A., Newman, E.A., Glial and neuronal control of brain blood flow. Nature 468 (2010), 232–243.
16. Bagowski, C.P., Myers, J.W., Ferrell, J.E. Jr., The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes. J. Biol. Chem. 276 (2001), 37708–37714.
17. Ballabh, P., Braun, A., Nedergaard, M., The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16 (2004), 1–13.
18. Bardehle, S., Krüger, M., Buggenthin, F., Schwausch, J., Ninkovic, J., Clevers, H., Snippert, H.J., Theis, F.J., Meyer-Luehmann, M., Bechmann, I., Dimou, L., Götz, M., Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat. Neurosci. 16 (2013), 580–586.
19. Barger, S.W., Chavis, J.A., Drew, P.D., Dehydroepiandrosterone inhibits microglial nitric oxide production in a stimulus-specific manner. J. Neurosci. Res. 62 (2000), 503–509.
20. Barreto, G.E., Gonzalez, J., Torres, Y., Morales, L., Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury. Neurosci. Res. 71 (2011), 107–113.
21. Baulieu, E.E., Robel, P., Schumacher, M., Neurosteroids: beginning of the story. Int. Rev. Neurobiol. 46 (2001), 1–32.
22. Baulieu, E.E., Steroid hormones in the brain: several mechanisms?. Fuxe, K., Gustafsson, J.A., Wetterberg, L., (eds.) Steroid Hormone Regulation of the Brain, 1981, Pergamon Press, Oxford, 3–14.
23. Baulieu, E.E., Dehydroepiandrosterone (DHEA): a fountain of youth?. J. Clin. Endocrinol. Metab. 81 (1996), 3147–3151.
24. Beckley, E.H., Finn, D.A., Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility. Pharmacol. Biochem. Behav. 87 (2007), 412–419.
25. Belelli, D., Herd, M.B., The contraceptive agent Provera enhances GABA(A) receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids?. J. Neurosci. 23 (2003), 10013–10020.
26. Bentel, J.M., Birrell, S.N., Pickering, M.A., Holds, D.J., Horsfall, D.J., Tilley, W.D., Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. Mol. Cell. Endocrinol. 154 (1999), 11–20.
27. Bentzer, P., Davidsson, H., Grände, P.O., Microdialysis-based long-term measurements of energy-related metabolites in the rat brain following a fluid percussion trauma. J. Neurotrauma 17 (2000), 441–447.
28. Betz, A.L., Coester, H.C., Effect of steroids on edema and sodium uptake of the brain during focal ischemia in rats. Stroke 21 (1990), 1199–1204.
29. Białek, M., Zaremba, P., Borowicz, K.K., Czuczwar, S.J., Neuroprotective role of testosterone in the nervous system. Pol. J. Pharmacol. 56 (2004), 509–518.
30. Boto, G.R., Gómez, P.A., De la Cruz, J., Lobato, R.D., A historical analysis of severe head injury. Neurosurg. Rev. 32 (2009), 343–353.
31. Burda, J.E., Sofroniew, M.V., Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 81 (2014), 229–248.
32. Bush, T.G., Puvanachandra, N., Horner, C.H., Polito, A., Ostenfeld, T., Svendsen, C.N., Mucke, L., Johnson, M.H., Sofroniew, M.V., Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23 (1999), 297–308.
33. Cai, W., Zhu, Y., Furuya, K., Li, Z., Sokabe, M., Chen, L., Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 55 (2008), 127–138.
34. Cervantes, M., González-Vidal, M.D., Ruelas, R., Escobar, A., Moralí, G., Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus. Arch. Med. Res. 33 (2002), 6–14.
35. Chao, T.C., Van Alten, P.J., Walter, R.J., Steroid sex hormones and macrophage function: modulation of reactive oxygen intermediates and nitrite release. Am. J. Reprod. Immunol. 32 (1994), 43–52.
36. Charalampopoulos, I., Remboutsika, E., Margioris, A.N., Gravanis, A., Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol. Metab. 19 (2008), 300–307.
37. Chase, A., Traumatic brain injury: no benefit of progesterone therapy in patients with TBI. Nat. Rev. Neurol., 11, 2015, 65.
38. Chen, J., Chopp, M., Li, Y., Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J. Neurol. Sci. 171 (1999), 24–30.
39. Chen, J., Zhang, C., Jiang, H., Li, Y., Zhang, L., Robin, A., Katakowski, M., Lu, M., Chopp, M., Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J. Cereb. Blood Flow Metab. 25 (2005), 281–290.
40. Cherian, L., Goodman, J.C., Robertson, C.S., Brain nitric oxide changes after controlled cortical impact injury in rats. J. Neurophysiol. 83 (2000), 2171–2178.
41. Cherian, L., Hlatky, R., Robertson, C.S., Nitric oxide in traumatic brain injury. Brain Pathol. 14 (2004), 195–201.
42. Chow, J., Ogunshola, O., Fan, S.Y., Li, Y., Ment, L.R., Madri, J.A., Astrocyte-derived VEGF mediates survival and tube stabilization of hypoxic brain microvascular endothelial cells in vitro. Brain Res. Dev. Brain Res. 130 (2001), 123–132.
43. Ciriza, I., Azcoitia, I., Garcia-Segura, L.M., Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J. Neuroendocrinol. 16 (2004), 58–63.
44. Ciriza, I., Carrero, P., Frye, C.A., Garcia-Segura, L.M., Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J. Neurobiol. 66 (2006), 916–928.
45. Clarkson, A.N., Huang, B.S., Macisaac, S.E., Mody, I., Carmichael, S.T., Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 468 (2010), 305–309.
46. Coirini, H., Gouézou, M., Liere, P., Delespierre, B., Pianos, A., Eychenne, B., Schumacher, M., Guennoun, R., 3 Beta-hydroxysteroid dehydrogenase expression in rat spinal cord. Neuroscience 113 (2002), 883–891.
47. Colangelo, A.M., Alberghina, L., Papa, M., Astrogliosis as a therapeutic target for neurodegenerative diseases. Neurosci. Lett. 565 (2014), 59–64.
48. Compagnone, N.A., Mellon, S.H., Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 4678–4683.
49. Compagnone, N.A., Bulfone, A., Rubenstein, J.L., Mellon, S.H., Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology 136 (1995), 2689–2696.
50. Compagnone, N.A., Bulfone, A., Rubenstein, J.L., Mellon, S.H., Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology 136 (1995), 5212–5223.
51. Compagnone, N.A., Treatments for spinal cord injury: is there hope in neurosteroids?. J. Steroid Biochem. Mol. Biol. 109 (2008), 307–313.
52. Coomber, B., Gibson, C.L., Sustained levels of progesterone prior to the onset of cerebral ischemia are not beneficial to female mice. Brain Res. 1361 (2010), 124–132.
53. Coronel, M.F., Labombarda, F., Villar, M.J., De Nicola, A.F., González, S.L., Progesterone prevents allodynia after experimental spinal cord injury. J. Pain 12 (2011), 71–83.
54. Coronel, M.F., Labombarda, F., De Nicola, A.F., González, S.L., Progesterone reduces the expression of spinal cyclooxygenase-2 and inducible nitric oxide synthase and prevents allodynia in a rat model of central neuropathic pain. Eur. J. Pain 18 (2014), 348–359.
55. Corpéchot, C., Robel, P., Axelson, M., Sjövall, J., Baulieu, E.E., Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U. S. A. 78 (1981), 4704–4707.
56. Corpéchot, C., Robel, P., Lachapelle, F., Baumann, N., Axelson, M., Sjövall, J., Baulieu, E.E., Free and sulfo-conjugated dehydroepiandrosterone in the brain of mice with myelin biosynthesis disorders. C. R. Seances Acad. Sci. III 292 (1981), 231–234.
57. Corpéchot, C., Synguelakis, M., Talha, S., Axelson, M., Sjövall, J., Vihko, R., Baulieu, E.E., Robel, P., Pregnenolone and its sulfate ester in the rat brain. Brain Res. 270 (1983), 119–125.
58. Cregg, J.M., DePaul, M.A., Filous, A.R., Lang, B.T., Tran, A., Silver, J., Functional regeneration beyond the glial scar. Exp. Neurol. 253 (2014), 197–207.
59. Cutler, S.M., Vanlandingham, J.W., Stein, D.G., Tapered progesterone withdrawal promotes long-term recovery following brain trauma. Exp. Neurol. 200 (2006), 378–385.
60. De Nicola, A.F., Gonzalez, S.L., Labombarda, F., González Deniselle, M.C., Garay, L., Guennoun, R., Schumacher, M., Progesterone treatment of spinal cord injury: effects on receptors, neurotrophins, and myelination. J. Mol. Neurosci. 28 (2006), 3–15.
61. de Souza, D.K., Ribeiro, M.F., Kucharski, L.C., Effects of dehydroepiandrosterone (DHEA) and lactate on glucose uptake in the central nervous system. Neurosci. Lett. 507 (2012), 62–66.
62. Demirgören, S., Majewska, M.D., Spivak, C.E., London, E.D., Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience 45 (1991), 127–135.
63. Di Michele, F., Lekieffre, D., Pasini, A., Bernardi, G., Benavides, J., Romeo, E., Increased neurosteroids synthesis after brain and spinal cord injury in rats. Neurosci. Lett. 284 (2000), 65–68.
64. Di Santo, E., Foddi, M.C., Ricciardi-Castagnoli, P., Mennini, T., Ghezzi, P., DHEAS inhibits TNF production in monocytes, astrocytes and microglial cells. Neuroimmunomodulation 3 (1996), 285–288.
65. Dirnagl, U., Iadecola, C., Moskowitz, M.A., Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (1999), 391–397.
66. Djebaili, M., Guo, Q., Pettus, E.H., Hoffman, S.W., Stein, D.G., The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficit after traumatic brain injury in rats. J. Neurotrauma 22 (2005), 106–118.
67. Dogan, A., Başkaya, M.K., Rao, V.L., Rao, A.M., Dempsey, R.J., Intraluminal suture occlusion of the middle cerebral artery in Spontaneously Hypertensive rats. Neurol. Res. 20 (1998), 265–270.
68. Dringen, R., Gutterer, J.M., Hirrlinger, J., Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267 (2000), 4912–4916.
69. Dupont, E., Simard, J., Luu-The, V., Labrie, F., Pelletier, G., Localization of 3 beta-hydroxysteroid dehydrogenase in rat brain as studied by in situ hybridization. Mol. Cell. Neurosci. 5 (1994), 119–123.
70. Duszczyk-Budhathoki, M., Olczak, M., Lehner, M., Majewska, M.D., Administration of thimerosal to infant rats increases overflow of glutamate and aspartate in the prefrontal cortex: protective role of dehydroepiandrosterone sulfate. Neurochem. Res. 37 (2012), 436–447.
71. Ehring, G.R., Kerschbaum, H.H., Eder, C., Neben, A.L., Fanger, C.M., Khoury, R.M., Negulescu, P.A., Cahalan, M.D., A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K+ channels Ca2+ signaling, and gene expression in T lymphocytes. J. Exp. Med. 188 (1998), 1593–1602.
72. Eldar-Geva, T., Margalioth, E.J., Brooks, B., Algur, N., Zylber-Haran, E., Diamant, Y.Z., The origin of serum progesterone during the follicular phase of menotropin-stimulated cycles. Hum. Reprod. 13 (1998), 9–14.
73. Elkabes, S., Nicot, A.B., Sex steroids and neuroprotection in spinal cord injury: a review of preclinical investigations. Exp. Neurol. 259 (2014), 28–37.
74. Faivre, E., Skildum, A., Pierson-Mullany, L., Lange, C.A., Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids 70 (2005), 418–426.
75. Farooque, M., Suo, Z., Arnold, P.M., Wulser, M.J., Chou, C.T., Vancura, R.W., Fowler, S., Festoff, B.W., Gender-related differences in recovery of locomotor function after spinal cord injury in mice. Spinal Cord. 44 (2006), 182–187.
76. Farrant, M., Nusser, Z., Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 6 (2005), 215–229.
77. Faulkner, J.R., Herrmann, J.E., Woo, M.J., Tansey, K.E., Doan, N.B., Sofroniew, M.V., Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24 (2004), 2143–2155.
78. Feeser, V.R., Loria, R.M., Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions. J. Neuroimmunol. 237 (2011), 4–12.
79. Feigin, V.L., Forouzanfar, M.H., Krishnamurthi, R., Mensah, G.A., Connor, M., Bennett, D.A., Moran, A.E., Sacco, R.L., Anderson, L., Truelsen, T., O'Donnell, M., Venketasubramanian, N., Barker-Collo, S., Lawes, C.M., Wang, W., Shinohara, Y., Witt, E., Ezzati, M., Naghavi, M., Murray, C., Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010), the GBD Stroke Experts Group, Global and regional burden of stroke during 19902010-: findings from the Global Burden of Disease Study 2010. Lancet 383 (2014), 245–254.
80. Fiore, C., Inman, D.M., Hirose, S., Noble, L.J., Igarashi, T., Compagnone, N.A., Treatment with the neurosteroid dehydroepiandrosterone promotes recovery of motor behavior after moderate contusive spinal cord injury in the mouse. J. Neurosci. Res. 75 (2004), 391–400.
81. Fodor, L., Boros, A., Dezso, P., Maksay, G., Expression of heteromeric glycine receptor-channels in rat spinal cultures and inhibition by neuroactive steroids. Neurochem. Int. 49 (2006), 577–583.
82. Fréchou, M., Zhang, S., Liere, P., Delespierre, B., Soyed, N., Pianos, A., Schumacher, M., Mattern, C., Guennoun, R., Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection. Neuropharmacology 97 (2015), 394–403.
83. Frye, C.A., Scalise, T.J., Anti-seizure effects of progesterone and 3alpha, 5alpha-tHP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 25 (2000), 407–420.
84. Frye, C.A., Walf, A.A., Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim testbehavior of proestrous rats. Horm. Behav. 41 (2002), 306–315.
85. Görlach, C., Hortobágyi, T., Hortobágyi, S., Benyó, Z., Relton, J., Whalley, E.T., Wahl, M., Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury. J. Neurotrauma 18 (2001), 833–838.
86. Garay, L., Tüngler, V., Deniselle, M.C., Lima, A., Roig, P., De Nicola, A.F., Progesterone attenuates demyelination and microglial reaction in the lysolecithin-injured spinal cord. Neuroscience 192 (2011), 588–597.
87. García-Estrada, J., Del Rio, J.A., Luquin, S., Soriano, E., Garcia-Segura, L.M., Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res. 628 (1993), 271–279.
88. García-Estrada, J., Luquín, S., Fernández, A.M., Garcia-Segura, L.M., Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int. J. Dev. Neurosci. 17 (1999), 145–151.
89. Garcia-Ovejero, D., González, S., Paniagua-Torija, B., Lima, A., Molina-Holgado, E., De Nicola, A.F., Labombarda, F., Progesterone reduces secondary damage, preserves white matter, and improves locomotor outcome after spinal cord contusion. J. Neurotrauma 31 (2014), 857–871.
90. Garcia-Segura, L.M., Wozniak, A., Azcoitia, I., Rodriguez, J.R., Hutchison, R.E., Hutchison, J.B., 1999 Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience 89 (1999), 567–578.
91. Geddes, R.I., Sribnick, E.A., Sayeed, I., Stein, D.G., Progesterone treatment shows benefit in a pediatric model of moderate to severe bilateral brain injury. PLoS One, 9, 2014, e87252.
92. Gibson, C.L., Murphy, S.P., Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. J. Cereb. Blood Flow Metab. 24 (2004), 805–813.
93. Gibson, C.L., Constantin, D., Prior, M.J., Bath, P.M., Murphy, S.P., Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp. Neurol. 193 (2005), 522–530.
94. Gibson, C.L., Coomber, B., Murphy, S.P., Progesterone is neuroprotective following cerebral ischaemia in reproductively ageing female mice. Brain 134 (2011), 2125–2133.
95. Giudetti, A.M., Romano, A., Lavecchia, A.M., Gaetani, S., The role of brain cholesterol and its oxidized products in Alzheimer's disease. Curr. Alzheimer Res. 13 (2016), 198–205.
96. Gonzalez, S.L., Labombarda, F., Gonzalez Deniselle, M.C., Mougel, A., Guennoun, R., Schumacher, M., De Nicola, A.F., Progesterone neuroprotection in spinal cord trauma involves up-regulation of brain-derived neurotrophic factor in motoneurons. J. Steroid Biochem. Mol. Biol. 94 (2005), 143–149.
97. Goss, J.R., Taffe, K.M., Kochanek, P.M., DeKosky, S.T., The antioxidant enzymes glutathione peroxidase and catalase increase following traumatic brain injury in the rat. Exp. Neurol. 146 (1997), 291–294.
98. Goss, C.W., Hoffman, S.W., Stein, D.G., Behavioral effects and anatomic correlates after brain injury: a progesterone dose-response study. Pharmacol. Biochem. Behav. 76 (2003), 231–242.
99. Guennoun, R., Labombarda, F., Gonzalez Deniselle, M.C., Liere, P., De Nicola, A.F., Schumacher, M., Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection. J. Steroid Biochem. Mol. Biol. 146 (2015), 48–61.
100. Gunn, B.G., Brown, A.R., Lambert, J.J., Belelli, D., Neurosteroids and GABA(A) receptor interactions: a focus on stress. Front. Neurosci., 5, 2011, 131.
101. Guo, Q., Sayeed, I., Baronne, L.M., Hoffman, S.W., Guennoun, R., Stein, D.G., Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp. Neurol. 198 (2006), 469–478.
102. Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., Gannon, B., Jones, D.H., Jennum, P., Jordanova, A., Jönsson, L., Karampampa, K., Knapp, M., Kobelt, G., Kurth, T., Lieb, R., Linde, M., Ljungcrantz, C., Maercker, A., Melin, B., Moscarelli, M., Musayev, A., Norwood, F., Preisig, M., Pugliatti, M., Rehm, J., Salvador-Carulla, L., Schlehofer, B., Simon, R., Steinhausen, H.C., Stovner, L.J., Vallat, J.M., Van den Bergh, P., van Os, J., Vos, P., Xu, W., Wittchen, H.U., Jönsson, B., Olesen, J., CDBE2010Study Group, Cost of disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 21 (2011), 718–779.
103. Hüttemann, M., Lee, I., Pecinova, A., Pecina, P., Przyklenk, K., Doan, J.W., Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease. J. Bioenerg. Biomembr. 40 (2008), 445–456.
104. Haan, N., Zhu, B., Wang, J., Wei, X., Song, B., Crosstalk between macrophages and astrocytes affects proliferation, reactive phenotype and inflammatory response, suggesting a role during reactive gliosis following spinal cord injury. J. Neuroinflammation, 12, 2015, 109.
105. Habib, P., Dreymueller, D., Ludwig, A., Beyer, C., Dang, J., Sex steroid hormone-mediated functional regulation of microglia-like BV-2 cells during hypoxia. J. Steroid Biochem. Mol. Biol. 138 (2013), 195–205.
106. Habib, P., Dang, J., Slowik, A., Victor, M., Beyer, C., Hypoxia-induced gene expression of aquaporin-4, cyclooxygenase-2 and hypoxia-inducible factor 1α in rat cortical astroglia is inhibited by 17β-estradiol and progesterone. Neuroendocrinology 99 (2014), 156–167.
107. Habib, P., Slowik, A., Zendedel, A., Johann, S., Dang, J., Beyer, C., Regulation of hypoxia-induced inflammatory responses and M1-M2 phenotype switch of primary rat microglia by sex steroids. J. Mol. Neurosci. 52 (2014), 277–285.
108. Hammer, F., Compagnone, N.A., Vigne, J.L., Bair, S.R., Mellon, S.H., Transcriptional regulation of P450scc gene expression in the embryonic rodent nervous system. Endocrinology 145 (2004), 901–912.
109. Hauben, E., Mizrahi, T., Agranov, E., Schwartz, M., Sexual dimorphism in the spontaneous recovery from spinal cord injury: a gender gap in beneficial autoimmunity?. Eur. J. Neurosci. 16 (2002), 1731–1740.
110. Havelock, J.C., Auchus, R.J., Rainey, W.E., The rise in adrenal androgen biosynthesis: adrenarche. Semin. Reprod. Med. 22 (2004), 337–347.
111. He, J., Evans, C.O., Hoffman, S.W., Oyesiku, N.M., Stein, D.G., Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp. Neurol. 189 (2004), 404–412.
112. Hill, K.K., Roemer, S.C., Churchill, M.E., Edwards, D.P., Structural and functional analysis of domains of the progesterone receptor. Mol. Cell. Endocrinol. 348 (2012), 418–429.
113. Hill, M., Dušková, M., Stárka, L., Dehydroepiandrosterone, its metabolites and ion channels. J. Steroid Biochem. Mol. Biol. 145 (2015), 293–314.
114. Hoffman, S.W., Virmani, S., Simkins, R.M., Stein, D.G., The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J. Neurotrauma 20 (2003), 859–870.
115. Hueston, C.M., Deak, T., On the time course, generality, and regulation of plasma progesterone release in male rats by stress exposure. Endocrinology 155 (2014), 3527–3537.
116. Irwin, R.P., Lin, S.Z., Rogawski, M.A., Purdy, R.H., Paul, S.M., Steroid potentiation and inhibition of N-methyl-d-aspartate receptor-mediated intracellular Ca + + responses: structure-activity studies. J. Pharmacol. Exp. Ther. 271 (1994), 677–682.
117. Ishihara, Y., Kawami, T., Ishida, A., Yamazaki, T., Allopregnanolone-mediated protective effects of progesterone on tributyltin-induced neuronal injury in rat hippocampal slices. J. Steroid Biochem. Mol. Biol. 135 (2013), 1–6.
118. Ishrat, T., Sayeed, I., Atif, F., Stein, D.G., Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res. 1257 (2009), 94–101.
119. Ishrat, T., Sayeed, I., Atif, F., Hua, F., Stein, D.G., Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp. Neurol. 226 (2010), 183–190.
120. Ishrat, T., Sayeed, I., Atif, F., Hua, F., Stein, D.G., Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway. Neuroscience 210 (2012), 442–450.
121. Jacobsen, B.M., Horwitz, K.B., Progesterone receptors, their isoforms and progesterone regulated transcription. Mol. Cell. Endocrinol. 357 (2012), 18–29.
122. Jacobsen, B.M., Jambal, P., Schittone, S.A., Horwitz, K.B., ALU repeats in promoters are position-dependent co-response elements (coRE) that enhance or repress transcription by dimeric and monomeric progesterone receptors. Mol. Endocrinol. 23 (2009), 989–1000.
123. Janner, D., da, R., Jacob, M.H., Jahn, M.P., Kucharski, L.C., Ribeiro, M.F., Dehydroepiandrosterone effects on Akt signaling modulation in central nervous system of young and aged healthy rats. J. Steroid Biochem. Mol. Biol. 122 (2010), 142–148.
124. Jayakumar, A.R., Norenberg, M.D., The Na-K-Cl Co-transporter in astrocyte swelling. Metab. Brain Dis. 25 (2010), 31–38.
125. Jiang, N., Chopp, M., Stein, D., Feit, H., Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res. 735 (1996), 101–107.
126. Jiang, C., Wang, J., Li, X., Liu, C., Chen, N., Hao, Y., Progesterone exerts neuroprotective effects by inhibiting inflammatory response after stroke. Inflamm. Res. 58 (2009), 619–624.
127. Jin, K., Zhu, Y., Sun, Y., Mao, X.O., Xie, L., Greenberg, D.A., Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 11946–11950.
128. Johann, S., Beyer, C., Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. J. Steroid Biochem. Mol. Biol. 137 (2013), 71–81.
129. Juhász-Vedres, G., Rózsa, E., Rákos, G., Dobszay, M.B., Kis, Z., Wölfling, J., Toldi, J., Párducz, A., Farkas, T., Dehydroepiandrosterone sulfate is neuroprotective when administered either before or after injury in a focal cortical cold lesion model. Endocrinology 147 (2006), 683–686.
130. Jung-Testas, I., Hu, Z.Y., Baulieu, E.E., Robel, P., Neurosteroids: biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology 125 (1989), 2083–2091.
131. Kaasik, A., Safiulina, D., Kalda, A., Zharkovsky, A., Dehydroepiandrosterone with other neurosteroids preserve neuronal mitochondria from calcium overload. J. Steroid Biochem. Mol. Biol. 87 (2003), 97–103.
132. Karishma, K.K., Herbert, J., Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16 (2002), 445–453.
133. Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., Chambon, P., Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9 (1990), 1603–1614.
134. Kasturi, B.S., Stein, D.G., Progesterone decreases cortical and sub-cortical edema in young and aged ovariectomized rats with brain injury. Restor. Neurol. Neurosci. 27 (2009), 265–275.
135. Kibaly, C., Patte-Mensah, C., Mensah-Nyagan, A.G., Molecular and neurochemical evidence for the biosynthesis of dehydroepiandrosterone in the adult rat spinal cord. J. Neurochem. 93 (2005), 1220–1230.
136. Kimonides, V.G., Khatibi, N.H., Svendsen, C.N., Sofroniew, M.V., Herbert, J., 1998 Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 1852–1857.
137. Kipper-Galperin, M., Galilly, R., Danenberg, H.D., Brenner, T., Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor alpha and interleukin-6 in astrocytes. Int. J. Dev. Neurosci. 17 (1999), 765–775.
138. Klieber, M.A., Underhill, C., Hammond, G.L., Muller, Y.A., Corticosteroid-binding globulin, a structural basis for steroid transport and proteinase-triggered release. J. Biol. Chem. 282 (2007), 29594–29603.
139. Kokona, D., Charalampopoulos, I., Pediaditakis, I., Gravanis, A., Thermos, K., The neurosteroid dehydroepiandrosterone (DHEA) protects the retina from AMPA-induced excitotoxicity: nGF TrkA receptor involvement. Neuropharmacology 62 (2012), 2106–2117.
140. Kumon, Y., Kim, S.C., Tompkins, P., Stevens, A., Sakaki, S., Loftus, C.M., Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia. J. Neurosurg. 92 (2000), 848–852.
141. Lür, G., Rákos, G., Juhász-Vedres, G., Farkas, T., Kis, Z., Toldi, J., Effects of dehydroepiandrosterone sulfate on the evoked cortical activity of controls and of brain-injured rats. Cell. Mol. Neurobiol. 26 (2006), 1505–1519.
142. Labombarda, F., Gonzalez, S., Roig, P., Lima, A., Guennoun, R., Schumacher, M., De Nicola, A.F., Modulation of NADPH-diaphorase and glial fibrillary acidic protein by progesterone in astrocytes from normal and injured rat spinal cord. J. Steroid Biochem. Mol. Biol. 73 (2000), 159–169.
143. Labombarda, F., Gonzalez, S., Gonzalez Deniselle, M.C., Garay, L., Guennoun, R., Schumacher, M., De Nicola, A.F., Progesterone increases the expression of myelin basic protein and the number of cells showing NG2 immunostaining in the lesioned spinal cord. J. Neurotrauma 23 (2006), 181–192.
144. Labombarda, F., Pianos, A., Liere, P., Eychenne, B., Gonzalez, S., Cambourg, A., De Nicola, A.F., Schumacher, M., Guennoun, R., Injury elicited increase in spinal cord neurosteroid content analyzed by gas chromatography mass spectrometry. Endocrinology 147 (2006), 1847–1859.
145. Labombarda, F., González, S.L., Lima, A., Roig, P., Guennoun, R., Schumacher, M., de Nicola, A.F., Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia 57 (2009), 884–897.
146. Labombarda, F., Meffre, D., Delespierre, B., Krivokapic-Blondiaux, S., Chastre, A., Thomas, P., Pang, Y., Lydon, J.P., Gonzalez, S.L., De Nicola, A.F., Schumacher, M., Guennoun, R., Membrane progesterone receptors localization in the mouse spinal cord. Neuroscience 166 (2010), 94–106.
147. Labombarda, F., González, S., Lima, A., Roig, P., Guennoun, R., Schumacher, M., De Nicola, A.F., Progesterone attenuates astro- and microgliosis and enhances oligodendrocyte differentiation following spinal cord injury. Exp. Neurol. 231 (2011), 135–146.
148. Labombarda, F., Ghoumari, A.M., Liere, P., De Nicola, A.F., Schumacher, M., Guennoun, R., Neuroprotection by steroids after neurotrauma in organotypic spinal cord cultures: a key role for progesterone receptors and steroidal modulators of GABA(A) receptors. Neuropharmacology 71 (2013), 46–55.
149. Laing, R.J., Jakubowski, J., Laing, R.W., Middle cerebral artery occlusion without craniectomy in rats. Which method works best?. Stroke 24 (1993), 294–297.
150. Lang, F., Busch, G.L., Ritter, M., Völkl, H., Waldegger, S., Gulbins, E., Häussinger, D., Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 78 (1998), 247–306.
151. Lange, C.A., Gioeli, D., Hammes, S.R., Marker, P.C., Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu. Rev. Physiol. 69 (2007), 171–199.
152. Lapchak, P.A., Chapman, D.F., Nunez, S.Y., Zivin, J.A., Dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord ischemia model: possible involvement of GABA(A) receptors. Stroke 31 (2000), 1953–1956 (discussion 1957).
153. Lazaridis, I., Charalampopoulos, I., Alexaki, V.I., Avlonitis, N., Pediaditakis, I., Efstathopoulos, P., Calogeropoulou, T., Castanas, E., Gravanis, A., Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis. PLoS Biol., 9, 2011, e1001051.
154. Le Goascogne, C., Robel, P., Gouézou, M., Sananès, N., Baulieu, E.E., Waterman, M., Neurosteroids: cytochrome P-450scc in rat brain. Science 237 (1987), 1212–1215.
155. Le Goascogne, C., Sananès, N., Gouézou, M., Takemori, S., Kominami, S., Baulieu, E.E., Robel, P., Immunoreactive cytochrome P-450(17 alpha) in rat and guinea-pig gonads, adrenal glands and brain. J. Reprod. Fertil. 93 (1991), 609–622.
156. Lee, R.J., Kim, J.K., Chao, D., Kuo, L., Mally, A., McClean, M.E., Pemberton, H.E., Wilmington, A.R., Wong, J., Murphy, S.P., Progesterone and allopregnanolone improves stroke outcome in male mice via distinct mechanisms but neither promotes neurogenesis. J. Neurochem. 132 (2015), 32–37.
157. Lei, B., Mace, B., Dawson, H.N., Warner, D.S., Laskowitz, D.T., James, M.L., Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia. PLoS One, 9, 2014, e103969.
158. Leist, M., Nicotera, P., Calcium and neuronal death. Rev. Physiol. Biochem. Pharmacol. 132 (1998), 79–125.
159. Li, H., Klein, G., Sun, P., Buchan, A.M., Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia. Brain Res. 888 (2001), 263–266.
160. Li, Z., Zhou, R., Cui, S., Xie, G., Cai, W., Sokabe, M., Chen, L., Dehydroepiandrosterone sulfate prevents ischemia-induced impairment of long-term potentiation in rat hippocampal CA1 by up-regulating tyrosine phosphorylation of NMDA receptor. Neuropharmacology 51 (2006), 958–966.
161. Li, L., Lundkvist, A., Andersson, D., Wilhelmsson, U., Nagai, N., Pardo, A.C., Nodin, C., Ståhlberg, A., Aprico, K., Larsson, K., Yabe, T., Moons, L., Fotheringham, A., Davies, I., Carmeliet, P., Schwartz, J.P., Pekna, M., Kubista, M., Blomstrand, F., Maragakis, N., Nilsson, M., Pekny, M., Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 28 (2008), 468–481.
162. Li, Z., Cui, S., Zhang, Z., Zhou, R., Ge, Y., Sokabe, M., Chen, L., DHEA-neuroprotection and -neurotoxicity after transient cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 29 (2009), 287–296.
163. Li, Z., Wang, B., Kan, Z., Zhang, B., Yang, Z., Chen, J., Wang, D., Wei, H., Zhang, J.N., Jiang, R., Progesterone increases circulating endothelial progenitor cells and induces neural regeneration after traumatic brain injury in aged rats. J. Neurotrauma 29 (2012), 343–353.
164. Liebner, S., Czupalla, C.J., Wolburg, H., Current concepts of blood-brain barrier development. Int. J. Dev. Biol. 55 (2011), 467–476.
165. Liere, P., Pianos, A., Eychenne, B., Cambourg, A., Liu, S., Griffiths, W., Schumacher, M., Sjövall, J., Baulieu, E.E., Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain. J. Lipid Res. 45 (2004), 2287–2302.
166. Liere, P., Pianos, A., Eychenne, B., Cambourg, A., Bodin, K., Griffiths, W., Schumacher, M., Baulieu, E.E., Sjövall, J., Analysis of pregnenolone and dehydroepiandrosterone in rodent brain: cholesterol autoxidation is the key. J. Lipid Res. 50 (2009), 2430–2444.
167. Lin, D., Sugawara, T., Strauss 3rd, J.F., Clark, B.J., Stocco, D.M., Saenger, P., Rogol, A., Miller, W.L., Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267 (1995), 1828–1831.
168. Liu, A., Margaill, I., Zhang, S., Labombarda, F., Coqueran, B., Delespierre, B., Liere, P., Marchand-Leroux, C., O'Malley, B.W., Lydon, J.P., De Nicola, A.F., Sitruk-Ware, R., Mattern, C., Plotkine, M., Schumacher, M., Guennoun, R., Progesterone receptors: a key for neuroprotection in experimental stroke. Endocrinology 153 (2012), 3747–3757.
169. Liu, F., Liao, F., Li, W., Han, Y., Liao, D., Progesterone alters Nogo-a, GFAP and GAP-43 expression in a rat model of traumatic brain injury. Mol. Med. Rep. 9 (2014), 1225–1231.
170. Lopez-Rodriguez, A.B., Acaz-Fonseca, E., Giatti, S., Caruso, D., Viveros, M.P., Melcangi, R.C., Garcia-Segura, L.M., Correlation of brain levels of progesterone and dehydroepiandrosterone with neurological recovery after traumatic brain injury in female mice. Psychoneuroendocrinology 56 (2015), 1–11.
171. Magistretti, P.J., Pellerin, L., Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos. Trans. R Soc. Lond. B Biol. Sci. 354 (1999), 1155–1163.
172. Maksay, G., Laube, B., Betz, H., Subunit-specific modulation of glycine receptors by neurosteroids. Neuropharmacology 41 (2001), 369–376.
173. Malik, A.S., Narayan, R.K., Wendling, W.W., Cole, R.W., Pashko, L.L., Schwartz, A.G., Strauss, K.I., A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model. J. Neurotrauma 20 (2003), 463–476.
174. Maninger, N., Wolkowitz, O.M., Reus, V.I., Epel, E.S., Mellon, S.H., Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 30 (2009), 65–91.
175. Mathieu, M., Mensah-Nyagan, A.G., Vallarino, M., Do-Régo, J.L., Beaujean, D., Vaudry, D., Luu-The, V., Pelletier, G., Vaudry, H., Immunohistochemical localization of 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase in the brain of the African lungfish Protopterus annectens. J. Comp. Neurol. 438 (2001), 123–135.
176. Matsunaga, M., Ukena, K., Tsutsui, K., Expression and localization of cytochrome P450 17 alpha-hydroxylase/c17,20-lyase in the avian brain. Brain Res. 899 (2001), 112–122.
177. McColl, B.W., Allan, S.M., Rothwell, N.J., Systemic inflammation and stroke: aetiology, pathology and targets for therapy. Biochem. Soc. Trans. 35 (2007), 1163–1165.
178. Meffre, D., Delespierre, B., Gouézou, M., Leclerc, P., Vinson, G.P., Schumacher, M., Stein, D.G., Guennoun, R., The membrane-associated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury. J. Neurochem. 93 (2005), 1314–1326.
179. Meffre, D., Pianos, A., Liere, P., Eychenne, B., Cambourg, A., Schumacher, M., Stein, D.G., Guennoun, R., Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 148 (2007), 2505–2517.
180. Meffre, D., Labombarda, F., Delespierre, B., Chastre, A., De Nicola, A.F., Stein, D.G., Schumacher, M., Guennoun, R., Distribution of membrane progesterone receptor alpha in the male mouse and rat brain and its regulation after traumatic brain injury. Neuroscience 231 (2013), 111–124.
181. Melcangi, R.C., Garcia-Segura, L.M., Mensah-Nyagan, A.G., Neuroactive steroids: state of the art and new perspectives. Cell. Mol. Life Sci. 65 (2008), 777–797.
182. Mellon, S.H., Deschepper, C.F., Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 629 (1993), 283–292.
183. Mellon, S.H., Neurosteroid regulation of central nervous system development. Pharmacol. Ther. 116 (2007), 107–124.
184. Mensah-Nyagan, A.G., Feuilloley, M., Dupont, E., Do-Rego, J.L., Leboulenger, F., Pelletier, G., Vaudry, H., Immunocytochemical localization and biological activity of 3 beta-hydroxysteroid dehydrogenase in the central nervous system of the frog. J. Neurosci. 14 (1994), 7306–7318.
185. Mesiano, S., Jaffe, R.B., Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 18 (1997), 378–403.
186. Miller, W.L., Auchus, R.J., The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32 (2011), 81–151.
187. Miller, W.L., Steroid hormone synthesis in mitochondria. Mol. Cell. Endocrinol. 379 (2013), 62–73.
188. Milman, A., Rosenberg, A., Weizman, R., Pick, C.G., Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J. Neurotrauma 22 (2005), 1003–1010.
189. Milman, A., Zohar, O., Maayan, R., Weizman, R., Pick, C.G., DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injury. Eur. Neuropsychopharmacol. 18 (2008), 181–187.
190. Morfin, R., Lafaye, P., Cotillon, A.C., Nato, F., Chmielewski, V., Pompon, D., 7 alpha-hydroxy-dehydroepiandrosterone and immune response. Ann. N. Y. Acad. Sci. 917 (2000), 971–982.
191. Moriguchi, S., Yamamoto, Y., Ikuno, T., Fukunaga, K., Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice. J. Neurochem. 117 (2011), 879–891.
192. Moriguchi, S., Shinoda, Y., Yamamoto, Y., Sasaki, Y., Miyajima, K., Tagashira, H., Fukunaga, K., Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice. PLoS One, 8, 2013, e60863.
193. Muntwyler, R., Bologa, L., In vitro hormonal regulation of astrocyte proliferation. Schweiz. Arch. Neurol. Psychiatr. 140 (1989), 29–33.
194. Murphy, S.J., Littleton-Kearney, M.T., Hurn, P.D., Progesterone administration during reperfusion, but not preischemia alone, reduces injury in ovariectomized rats. J. Cereb. Blood Flow Metab. 22 (2002), 1181–1188.
195. Narayanan, R., Adigun, A.A., Edwards, D.P., Weigel, N.L., Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as aprogesterone receptor coactivator. Mol. Cell. Biol. 25 (2005), 264–277.
196. Nicholls, D.G., Budd, S.L., Mitochondria and neuronal survival. Physiol. Rev. 80 (2000), 315–360.
197. Nieschlag, E., Loriaux, D.L., Ruder, H.J., Zucker, I.R., Kirschner, M.A., Lipsett, M.B., The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J. Endocrinol. 57 (1973), 123–134.
198. Nilsen, J., Brinton, R.D., Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport 13 (2002), 825–830.
199. Nilupul Perera, M., Ma, H.K., Arakawa, S., Howells, D.W., Markus, R., Rowe, C.C., Donnan, G.A., Inflammation following stroke. J. Clin. Neurosci. 13 (2006), 1–8.
200. O'Connor, C.A., Cernak, I., Vink, R., Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats. Brain Res. 1062 (2005), 171–174.
201. O'Connor, C.A., Cernak, I., Johnson, F., Vink, R., Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats. Exp. Neurol. 205 (2007), 145–153.
202. Ozacmak, V.H., Sayan, H., The effects of 17beta estradiol, 17alpha estradiol and progesterone on oxidative stress biomarkers in ovariectomized female rat brain subjected to global cerebral ischemia. Physiol. Res. 58 (2009), 909–912.
203. Pan, D.S., Liu, W.G., Yang, X.F., Cao, F., Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury. Biomed. Environ. Sci. 20 (2007), 432–438.
204. Pang, Y., Dong, J., Thomas, P., Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and {epsilon} (mPR (and mPR{epsilon}) and mPRδ involvement in neurosteroid inhibition of apoptosis. Endocrinology 154 (2013), 283–295.
205. Papadopoulos, M.C., Verkman, A.S., Aquaporin-4 and brain edema. Pediatr. Nephrol. 22 (2007), 778–784.
206. Park-Chung, M., Malayev, A., Purdy, R.H., Gibbs, T.T., Farb, D.H., Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Res. 830 (1999), 72–87.
207. Parker, C.R. Jr., Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids 64 (1999), 640–647.
208. Patel, M.A., Modi, H.R., Katyare, S.S., Stimulation of oxidative energy metabolism in liver mitochondria from old and young rats by treatment with dehydroepiandrosterone (DHEA). A comparative study. Age (Dordr.) 29 (2007), 41–49.
209. Patte-Mensah, C., Penning, T.M., Mensah-Nyagan, A.G., Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord. J. Comp. Neurol. 477 (2004), 286–299.
210. Paul, S.M., Purdy, R.H., Neuroactive steroids. FASEB J. 6 (1992), 2311–2322.
211. Pediaditakis, I., Iliopoulos, I., Theologidis, I., Delivanoglou, N., Margioris, A.N., Charalampopoulos, I., Gravanis, A., Dehydroepiandrosterone: an ancestral ligand of neurotrophin receptors. Endocrinology 156 (2015), 16–23.
212. Pellerin, L., Bouzier-Sore, A.K., Aubert, A., Serres, S., Merle, M., Costalat, R., Magistretti, P.J., Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 55 (2007), 1251–1262.
213. Pelletier, G., Steroidogenic enzymes in the brain: morphological aspects. Prog. Brain Res. 181 (2010), 193–207.
214. Peng, L., Parpura, V., Verkhratsky, A., EDITORIAL neuroglia as a central element of neurological diseases: an underappreciated target for therapeutic intervention. Curr. Neuropharmacol. 12 (2014), 303–307.
215. Pettus, E.H., Wright, D.W., Stein, D.G., Hoffman, S.W., Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res. 1049 (2005), 112–119.
216. Radley, E., Akram, A., Grubb, B.D., Gibson, C.L., Investigation of the mechanisms of progesterone protection following oxygen-glucose deprivation in organotypic hippocampal slice cultures. Neurosci. Lett. 506 (2012), 131–135.
217. Rahmani, A., Shoae-Hassani, A., Keyhanvar, P., Kheradmand, D., Darbandi-Azar, A., Dehydroepiandrosterone stimulates nerve growth factor and brain derived neurotrophic factor in cortical neurons. Adv. Pharmacol. Sci., 2013(5), 2013.
218. Raso, G.M., Esposito, E., Vitiello, S., Iacono, A., Santoro, A., D'Agostino, G., Sasso, O., Russo, R., Piazza, P.V., Calignano, A., Meli, R., Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α. J. Neuroendocrinol. 23 (2011), 591–600.
219. Ribeiro, M.F., Garcia-Segura, L.M., Dehydroepiandrosterone regulates insulin-like growth factor-1 system in adult rat hypothalamus. Endocrine 17 (2002), 129–134.
220. Robel, P., Baulieu, E.E., Neuro-steroids: 3?-hydroxy-?(5)-derivatives in the rodent brain. Neurochem. Int. 7 (1985), 953–958.
221. Robert, F., Guennoun, R., Désarnaud, F., Do-Thi, A., Benmessahel, Y., Baulieu, E.E., Schumacher, M., Synthesis of progesterone in Schwann cells: regulation by sensory neurons. Eur. J. Neurosci. 13 (2001), 916–924.
222. Robertson, C.L., Puskar, A., Hoffman, G.E., Murphy, A.Z., Saraswati, M., Fiskum, G., Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats. Exp. Neurol. 197 (2006), 235–243.
223. Rone, M.B., Midzak, A.S., Issop, L., Rammouz, G., Jagannathan, S., Fan, J., Ye, X., Blonder, J., Veenstra, T., Papadopoulos, V., Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Mol. Endocrinol. 26 (2012), 1868–1882.
224. Roof, R.L., Hall, E.D., Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J. Neurotrauma 17 (2000), 367–388.
225. Roof, R.L., Duvdevani, R., Stein, D.G., Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor. Neurol. Neurosci. 4 (1992), 425–427.
226. Roof, R.L., Duvdevani, R., Stein, D.G., Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res. 607 (1993), 333–336.
227. Roof, R.L., Duvdevani, R., Braswell, L., Stein, D.G., Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 129 (1994), 64–69.
228. Roof, R.L., Duvdevani, R., Heyburn, J.W., Stein, D.G., Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp. Neurol. 138 (1996), 246–251.
229. Rouach, N., Koulakoff, A., Abudara, V., Willecke, K., Giaume, C., Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 322 (2008), 1551–1555.
230. Rouleau, P., Ung, R.V., Lapointe, N.P., Guertin, P.A., Hormonal and immunological changes in mice after spinal cord injury. J. Neurotrauma 24 (2007), 367–378.
231. Sachidanandan, D., Bera, A.K., Inhibition of the GABAA receptor by sulfated neurosteroids: a mechanistic comparison study between pregnenolone sulfate and dehydroepiandrosterone sulfate. J. Mol. Neurosci. 56 (2015), 868–877.
232. Sahin, B., Albayrak, B.S., Ismailoglu, O., Gorgulu, A., The effects of medroxy progesterone acetate on the pro-inflammatory cytokines, TNF-alpha and IL-1beta in the early phase of the spinal cord injury. Neurol. Res. 33 (2011), 63–67.
233. Sayeed, I., Guo, Q., Hoffman, S.W., Stein, D.G., Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann. Emerg. Med. 47 (2006), 381–389.
234. Sayeed, I., Parvez, S., Wali, B., Siemen, D., Stein, D.G., Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone. Brain Res. 16 (2009), 5–173.
235. Scarpin, K.M., Graham, J.D., Mote, P.A., Clarke, C.L., Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl. Recept Signal., 7, 2009, e009.
236. Schmid-Brunclik, N., Bürgi-Taboada, C., Antoniou, X., Gassmann, M., Ogunshola, O.O., Astrocyte responses to injury: vEGF simultaneously modulates cell death and proliferation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 (2008), R864–873.
237. Schumacher, M., Weill-Engerer, S., Liere, P., Robert, F., Franklin, R.J., Garcia-Segura, L.M., Lambert, J.J., Mayo, W., Melcangi, R.C., Parducz, A., Suter, U., Carelli, C., Baulieu, E.E., Akwa, Y., Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71 (2003), 3–29.
238. Schumacher, M., Sitruk-Ware, R., De Nicola, A.F., Progesterone and progestins: neuroprotection and myelin repair. Curr. Opin. Pharmacol. 8 (2008), 740–746.
239. Schumacher, M., Hussain, R., Gago, N., Oudinet, J.P., Mattern, C., Ghoumari, A.M., Progesterone synthesis in the nervous system: implications for myelination and myelin repair. Front. Neurosci., 6, 2012, 10.
240. Schumacher, M., Mattern, C., Ghoumari, A., Oudinet, J.P., Liere, P., Labombarda, F., Sitruk-Ware, R., De Nicola, A.F., Guennoun, R., Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog. Neurobiol. 113 (2014), 6–39.
241. Schumacher, M., Guennoun, R., Mattern, C., Oudinet, J.P., Labombarda, F., De Nicola, A.F., Liere, P., Analytical challenges for measuring steroid responses to stress, neurodegeneration and injury in the central nervous system. Steroids 103 (2015), 42–57.
242. Selye, H., Anesthetic effects of steroid hormones. Proc. Soc. Exp. Biol. Med. 88 (1941), 4553–4557.
243. Selye, H., Correlations between the chemical structure and pharmacological actions of the steroids. Endocrinology 30 (1942), 437–453.
244. Semyanov, A., Walker, M.C., Kullmann, D.M., Silver, R.A., Tonically active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci. 27 (2004), 262–269.
245. Shear, D.A., Galani, R., Hoffman, S.W., Stein, D.G., Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp. Neurol. 178 (2002), 59–67.
246. Shin, C.Y., Choi, J.W., Jang, E.S., Ju, C., Kim, W.K., Kim, H.C., Choi, C.R., Ko, K.H., Dehydroepiandrosterone inhibits the death of immunostimulated rat C6 glioma cells deprived of glucose. Brain Res. 922 (2001), 267–275.
247. Si, D., Wang, H., Wang, Q., Zhang, C., Sun, J., Wang, Z., Zhang, Z., Zhang, Y., Progesterone treatment improves cognitive outcome following experimental traumatic brain injury in rats. Neurosci. Lett. 553 (2013), 18–23.
248. Si, D., Li, J., Liu, J., Wang, X., Wei, Z., Tian, Q., Wang, H., Liu, G., Progesterone protects blood-brain barrier function and improves neurological outcome following traumatic brain injury in rats. Exp. Ther. Med. 8 (2014), 1010–1014.
249. Singh, M., Su, C., Ng, S., Non-genomic mechanisms of progesterone action in the brain. Front. Neurosci., 7, 2013, 159.
250. Sinor, A.D., Irvin, S.M., Cobbs, C.S., Chen, J., Graham, S.H., Greenberg, D.A., Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures. Brain Res. 812 (1998), 289–291.
251. Skildum, A., Faivre, E., Lange, C.A., Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol. Endocrinol. 19 (2005), 327–339.
252. Skolnick, B.E., Maas, A.I., Narayan, R.K., van der Hoop, R.G., MacAllister, T., Ward, J.D., Nelson, N.R., Stocchetti, N., SYNAPSE Trial Investigators, A clinical trial of progesterone for severe traumatic brain injury. N. Engl. J. Med. 371 (2014), 2467–2476.
253. Sleiter, N., Pang, Y., Park, C., Horton, T.H., Dong, J., Thomas, P., Levine, J.E., Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-releasing hormone release. Endocrinology 150 (2009), 3833–3844.
254. Slemmer, J.E., Shacka, J.J., Sweeney, M.I., Weber, J.T., Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr. Med. Chem. 15 (2008), 404–414.
255. Sofroniew, M.V., Vinters, H.V., Astrocytes: biology and pathology. Acta Neuropathol. 119 (2010), 7–35.
256. South, S.A., Deibler, G.E., Tzeng, S.F., Badache, A., Kirchner, M.G., Muja, N., De Vries, G.H., Myelin basic protein (MBP) and MBP peptides are mitogens for cultured astrocytes. Glia 29 (2000), 81–90.
257. Stárka, L., Dušková, M., Hill, M., Dehydroepiandrosterone: a neuroactive steroid. J. Steroid Biochem. Mol. Biol. 145 (2015), 254–260.
258. Stein, D.G., Geddes, R.I., Sribnick, E.A., Recent developments in clinical trials for the treatment of traumatic brain injury. Handb Clin Neurol. 127 (2015), 433–451.
259. Stein, D.G., Progesterone exerts neuroprotective effects after brain injury. Brain Res. Rev. 57 (2008), 386–397.
260. Stein, D.G., Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update. Neuroscience 191 (2011), 101–106.
261. Stein, D.G., On improving human clinical trials to the level of animal ischemic stroke studies. Metab. Brain Dis. 30 (2015), 469–471.
262. Su, C., Cunningham, R.L., Rybalchenko, N., Singh, M., Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling. Endocrinology 153 (2012), 4389–4400.
263. Svob Štrac, D., Jazvinšćak Jembrek, M., Erhardt, J., Mirković Kos, K., Peričić, D., Modulation of recombinant GABA(A) receptors by neurosteroid dehydroepiandrosterone sulfate. Pharmacology 89 (2012), 163–171.
264. Takimoto, G.S., Tung, L., Abdel-Hafiz, H., Abel, M.G., Sartorius, C.A., Richer, J.K., Jacobsen, B.M., Bain, D.L., Horwitz, K.B., Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure. J. Steroid Biochem. Mol. Biol. 85 (2003), 209–219.
265. Tang, H., Hua, F., Wang, J., Sayeed, I., Wang, X., Chen, Z., Yousuf, S., Atif, F., Stein, D.G., Progesterone and vitamin D: Improvement after traumatic brain injury in middle-aged rats. Horm. Behav. 64 (2013), 527–538.
266. Thomas, P., Pang, Y., Membrane progesterone receptors: evidence for neuroprotective, neurosteroid signaling and neuroendocrine functions in neuronal cells. Neuroendocrinology 96 (2012), 162–171.
267. Thomas, A.J., Nockels, R.P., Pan, H.Q., Shaffrey, C.I., Chopp, M., Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine (Phila Pa 1976) 24 (1999), 2134–2138.
268. Thomas, P., Pang, Y., Dong, J., Enhancement of cell surface expression and receptor functions of membrane progestin receptor α (mPRα) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors. Endocrinology 155 (2014), 1107–1119.
269. Thomas, P., Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front. Neuroendocrinol. 29 (2008), 292–312.
270. Ullian, E.M., Christopherson, K.S., Barres, B.A., Role for glia in synaptogenesis. Glia 47 (2004), 209–216.
271. van Weerden, W.M., Bierings, H.G., van Steenbrugge, G.J., de Jong, F.H., Schröder, F.H., Adrenal glands of mouse and rat do not synthesize androgens. Life Sci. 50 (1992), 857–861.
272. VanLandingham, J.W., Cutler, S.M., Virmani, S., Hoffman, S.W., Covey, D.F., Krishnan, K., Hammes, S.R., Jamnongjit, M., Stein, D.G., The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury. Neuropharmacology 51 (2006), 1078–1085.
273. Veiga, S., Garcia-Segura, L.M., Azcoitia, I., Neuroprotection by the steroids pregnenolone and dehydroepiandrosterone is mediated by the enzyme aromatase. J. Neurobiol. 56 (2003), 398–406.
274. Vink, R., Van Den Heuvel, C., Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury. Expert Opin. Investig. Drugs 13 (2004), 1263–1274.
275. Voskuhl, R.R., Peterson, R.S., Song, B., Ao, Y., Morales, L.B., Tiwari-Woodruff, S., Sofroniew, M.V., Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 29 (2009), 11511–11522.
276. Wali, B., Sayeed, I., Stein, D.G., Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury. Restor. Neurol. Neurosci. 29 (2011), 61–71.
277. Wali, B., Ishrat, T., Won, S., Stein, D.G., Sayeed, I., Progesterone in experimental permanent stroke: a dose-response and therapeutic time-window study. Brain 137 (2014), 486–502.
278. Walz, W., Role of astrocytes in the clearance of excess extracellular potassium. Neurochem. Int. 36 (2000), 291–300.
279. Wang, M.J., Huang, H.M., Chen, H.L., Kuo, J.S., Jeng, K.C., Dehydroepiandrosterone inhibits lipopolysaccharide-induced nitric oxide production in BV-2 microglia. J. Neurochem. 77 (2001), 830–838.
280. Wang, J., Jiang, C., Liu, C., Li, X., Chen, N., Hao, Y., Neuroprotective effects of progesterone following stroke in aged rats. Behav. Brain Res. 209 (2010), 119–122.
281. Wang, J., Zhao, Y., Liu, C., Jiang, C., Zhao, C., Zhu, Z., Progesterone inhibits inflammatory response pathways after permanent middle cerebral artery occlusion in rats. Mol. Med. Rep. 4 (2011), 319–324.
282. Wanner, I.B., Anderson, M.A., Song, B., Levine, J., Fernandez, A., Gray-Thompson, Z., Ao, Y., Sofroniew, M.V., Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci. 33 (2013), 12870–12886.
283. Waters, S.L., Miller, G.W., Aleo, M.D., Schnellmann, R.G., Neurosteroid inhibition of cell death. Am. J. Physiol. 273 (1997), F869–876.
284. Wiegratz, I., Kuhl, H., Progestogen therapies: differences in clinical effects?. Trends Endocrinol. Metab. 15 (2004), 277–285.
285. Williams, R.R., Henao, M., Pearse, D.D., Bunge, M.B., Permissive Schwann cell graft/spinal cord interfaces for axon regeneration. Cell Transplant. 24 (2015), 115–131.
286. Wong, R., Bath, P.M., Kendall, D., Gibson, C.L., Progesterone and cerebral ischaemia: the relevance of ageing. J. Neuroendocrinol. 25 (2013), 1088–1094.
287. Wong, R., Renton, C., Gibson, C.L., Murphy, S.J., Kendall, D.A., Bath, P.M., Progesterone Pre-Clinical Stroke Pooling Project Collaboration, Progesterone treatment for experimental stroke: an individual animal meta-analysis. J. Cereb. Blood Flow Metab. 33 (2013), 1362–1372.
288. Wright, D.W., Bauer, M.E., Hoffman, S.W., Stein, D.G., Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats. J. Neurotrauma 18 (2001), 901–909.
289. Wright, D.W., Kellermann, A.L., Hertzberg, V.S., Clark, P.L., Frankel, M., Goldstein, F.C., Salomone, J.P., Dent, L.L., Harris, O.A., Ander, D.S., Lowery, D.W., Patel, M.M., Denson, D.D., Gordon, A.B., Wald, M.M., Gupta, S., Hoffman, S.W., Stein, D.G., ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med. 49 (2007), 391–402 (402. e1–2).
290. Wright, D.W., Yeatts, S.D., Silbergleit, R., Palesch, Y.Y., Hertzberg, V.S., Frankel, M., Goldstein, F.C., Caveney, A.F., Howlett-Smith, H., Bengelink, E.M., Manley, G.T., Merck, L.H., Janis, L.S., Barsan, W.G., NETT Investigators, Very early administration of progesterone for acute traumatic brain injury. N. Engl. J. Med. 371 (2014), 2457–2466.
291. Wu, Z., Li, L., Zheng, L.T., Xu, Z., Guo, L., Zhen, X., Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation. J. Neurochem., 2015, 10.1111/jnc.13182.
292. Xiao, G., Wei, J., Yan, W., Wang, W., Lu, Z., Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit. Care, 12, 2008, R61.
293. Xydakis, M.S., Ling, G.S., Ecklund, J.M., Progesterone in traumatic brain injury. N. Engl. J. Med., 372, 2015, 1765.
294. Yabuki, Y., Shinoda, Y., Izumi, H., Ikuno, T., Shioda, N., Fukunaga, K., Dehydroepiandrosterone administration improves memory deficits following transient brain ischemia through sigma-1 receptor stimulation. Brain Res. 1622 (2015), 102–113.
295. Yao, X.L., Liu, J., Lee, E., Ling, G.S., McCabe, J.T., Progesterone differentially regulates pro- and anti-apoptotic gene expression in cerebral cortex following traumatic brain injury in rats. J. Neurotrauma 22 (2005), 656–668.
296. Yousuf, S., Atif, F., Sayeed, I., Tang, H., Stein, D.G., Progesterone in transient ischemic stroke: a dose-response study. Psychopharmacology (Berl.) 231 (2014), 3313–3323.
297. Yousuf, S., Sayeed, I., Atif, F., Tang, H., Wang, J., Stein, D.G., Delayed progesterone treatment reduces brain infarction and improves functional outcomes after ischemic stroke: a time-window study in middle-aged rats. J. Cereb. Blood Flow Metab. 34 (2014), 297–306.
298. Zhang, Z.G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. v., Chopp, M., VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106 (2000), 829–838.
299. Zheng, W., Watts, L.T., Holstein, D.M., Prajapati, S.I., Keller, C., Grass, E.H., Walter, C.A., Lechleiter, J.D., Purinergic receptor stimulation reduces cytotoxic edema and brain infarcts in mouse induced by photothrombosis by energizing glial mitochondria. PLoS One, 5, 2010, e14401.
300. Zou, J., Wang, Y.X., Lü, H.Z., Lu, P.H., Xu, X.M., Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons. Neurochem. Int. 56 (2010), 577–584.
301. Zukor, K., Belin, S., Wang, C., Keelan, N., Wang, X., He, Z., Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury. J. Neurosci. 33 (2013), 15350–15361.
302. Zuloaga, D.G., Yahn, S.L., Pang, Y., Quihuis, A.M., Oyola, M.G., Reyna, A., Thomas, P., Handa, R.J., Mani, S.K., Distribution and estrogen regulation of membrane progesterone receptor-β in the female rat brain. Endocrinology 153 (2012), 4432–4443.
303. Zup, S.L., Edwards, N.S., McCarthy, M.M., Sex- and age-dependent effects of androgens on glutamate-induced cell death and intracellular calcium regulation in the developing hippocampus. Neuroscience 281C (2014), 77–87.
304. Zwain, I.H., Yen, S.S., Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140 (1999), 3843–3852.